Contact
searchSearch
HMP Global

Volume 19 - Issue 4 - April, 2007

Feature

Case Report
Methamphetamine-Associated Acute Myocardial Infarction and Cardiogenic Shock with Normal Coronary Arteries: Refractory Global Co
08/01/2008
Jack P. Chen, MD, FACC, FSCAI, FCCP
J INVASIVE CARDIOL 2007;19:E89-E92 Case Report. A 19-year-old male college student was admitted with 2 days of progressive, intermittent substernal chest pain. He had driven home from his out-of-state campus, where 2 days earlier he had...
J INVASIVE CARDIOL 2007;19:E89-E92 Case Report. A 19-year-old male college student was admitted with 2 days of progressive, intermittent substernal chest pain. He had driven home from his out-of-state campus, where 2 days earlier he had...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
Catheter-Induced Left Main Coronary Artery Dissection Resulting in Abrupt Closure and Cardiac Arrest: Successful Stenting during
08/01/2008
Dervis Oral, MD; Cagdas Ozdol, MD; Eralp Tutar, MD
Left main coronary artery (LMCA) dissection is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). LMCA dissection is the harbinger of catastrophic vessel closure. It can be precipitated by the...
Left main coronary artery (LMCA) dissection is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). LMCA dissection is the harbinger of catastrophic vessel closure. It can be precipitated by the...
Left main coronary artery (LMCA)...
08/01/2008
Journal of Invasive Cardiology
Case Report
Late Stent Thrombosis Associated with Coronary Aneurysm Formation after Sirolimus-Eluting Stent Implantation
08/01/2008
Raphael A. Perry, MD, FRCP, BMBS, BSc; Shahid Aziz, BSc, MD, MRCP, MBChB; John L. Morris, MD, FRCP
J INVASIVE CARDIOL 2007;19:E96-E98 Drug-eluting stents (DES) have been shown to be superior to bare-metal stents (BMS) in reducing the need for repeat revascularization.1 Their use has increased rapidly with DES accounting for up to 80% of...
J INVASIVE CARDIOL 2007;19:E96-E98 Drug-eluting stents (DES) have been shown to be superior to bare-metal stents (BMS) in reducing the need for repeat revascularization.1 Their use has increased rapidly with DES accounting for up to 80% of...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
Complete Cypher‚Ñ¢ Stent Fracture and Migration in the Ostium of the Right Coronary Artery
08/01/2008
Jason T. Bradley, MD; Joseph D. Schmoker, MD; Harold L. Dauerman, MD
J INVASIVE CARDIOL 2007;19:E99-E101 Stent fracture has been reported with the Cypher™ sirolimus-eluting stent (Cordis Corp., Miami, Florida) in 4 patients since the introduction of drug-eluting stents in 2004.1,2 In all of these cases, the...
J INVASIVE CARDIOL 2007;19:E99-E101 Stent fracture has been reported with the Cypher™ sirolimus-eluting stent (Cordis Corp., Miami, Florida) in 4 patients since the introduction of drug-eluting stents in 2004.1,2 In all of these cases, the...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
Single Coronary Artery from Right Aortic Sinus with Septal Course of Left Anterior Descending Artery and Left circumflex Artery
08/01/2008
Narayanan Namboodiri, MBBS, MD, DM; Sivadasan Pillai Harikrishnan, MD, DM; Jaganmohan Achuthan Tharakan, MBBS, MD, DM
J INVASIVE CARDIOL 2007;19:E102-E103 The occurrence of a single coronary artery (SCA) in structurally normal heart is uncommon. This anomaly is often clinically benign and presents as an incidental finding during coronary angiography....
J INVASIVE CARDIOL 2007;19:E102-E103 The occurrence of a single coronary artery (SCA) in structurally normal heart is uncommon. This anomaly is often clinically benign and presents as an incidental finding during coronary angiography....
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
A Novel Method of Clot Extraction Using a FilterWire EX‚Ñ¢ in Acute Myocardial Infarction
08/01/2008
Raed A. Aqel, MD; Gilbert J. Zoghbi, MD, FACC; Ritesh Gupta, MD, MPH
J INVASIVE CARDIOL 2007;19:E104-E106 Acute myocardial infarction (MI) usually results from clot formation due to plaque rupture, platelet aggregation, and activation of the coagulation cascade.1,2 Contemporary therapy for acute MI involves...
J INVASIVE CARDIOL 2007;19:E104-E106 Acute myocardial infarction (MI) usually results from clot formation due to plaque rupture, platelet aggregation, and activation of the coagulation cascade.1,2 Contemporary therapy for acute MI involves...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
Extreme Coronary Guide Catheter Support: A Case of a Novel Telescopic Guide Catheter System with a Contralateral Aortic Wall Sup
08/01/2008
David L. Brown, MD, FACC, FACP, DO; Adam T. Stys, MD, FACC; William Lawson, MD, DDS
J INVASIVE CARDIOL 2007;19:E107-E110 Severe calcification and/or tortuosity of the coronary artery decrease the success of percutaneous coronary intervention (PCI). In such cases, adequate support of the guide catheter is of paramount...
J INVASIVE CARDIOL 2007;19:E107-E110 Severe calcification and/or tortuosity of the coronary artery decrease the success of percutaneous coronary intervention (PCI). In such cases, adequate support of the guide catheter is of paramount...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
Featured Case: Spontaneous Multivessel Coronary Vasospasm Leading to Cardiogenic Shock
08/01/2008
Ehtisham Mahmud, MD; Sotirios Tsimikas, MD; Guilherme Bromberg-Marin, MD
J INVASIVE CARDIOL 2007;19:E85-E88 Coronary vasospasm is a well-known cause of exercise-induced angina pectoris, Prinzmetal’s unstable angina, and myocardial infarction.1–6 In general, the prognosis of patients with isolated coronary...
J INVASIVE CARDIOL 2007;19:E85-E88 Coronary vasospasm is a well-known cause of exercise-induced angina pectoris, Prinzmetal’s unstable angina, and myocardial infarction.1–6 In general, the prognosis of patients with isolated coronary...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Feature
Catheter-Induced Left Main Coronary Artery Dissection Resulting in Abrupt Closure and Cardiac Arrest: Successful Stenting during
08/01/2008
Cagdas Ozdol, MD; Dervis Oral, MD; Eralp Tutar, MD
J INVASIVE CARDIOL 2007;19:E93-E95 Left main coronary artery (LMCA) dissection is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). LMCA dissection is the harbinger of catastrophic vessel...
J INVASIVE CARDIOL 2007;19:E93-E95 Left main coronary artery (LMCA) dissection is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). LMCA dissection is the harbinger of catastrophic vessel...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology

Column

Editorial Message
Apr-07
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, commentary, letters to the editor, articles from our Rapid Communication and Clinical Images sections, and online case reports, as well as...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, commentary, letters to the editor, articles from our Rapid Communication and Clinical Images sections, and online case reports, as well as...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology

News

Radiation Protection Systems
Rampart IC Secures Series B Financing to Fuel Strategic Growth and Expand Access to Radiation Safety Solutions
04/24/2025
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology...
04/24/2025
Cath Lab Digest
MEeting Update
SCAI Scientific Sessions 2025 Features Latest Clinical Innovations in Cardiology Care
04/24/2025
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.  
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.  
Whether you’re focused on...
04/24/2025
Cath Lab Digest
Scientific Statement
HRS and ACC Release Joint Scientific Statement on the Safety of Same-Day Discharge for Intracardiac Catheter Ablation Procedures
04/24/2025
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global...
04/24/2025
EP Lab Digest
(Reproduced with permission from NEJM AI, Lampert, 2025. Copyright 2025 Massachusetts Medical Society)
AI: HCM
AI Algorithm Can Help Identify High-Risk Heart Patients to Quickly Diagnose, Expedite, and Improve Care
04/24/2025
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze...
04/24/2025
Cath Lab Digest
News
The Heart Rhythm Society Announces Framework for Establishing Atrial Fibrillation Centers of Excellence and Key Operational Standards
04/23/2025
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS)...
04/23/2025
EP Lab Digest
Peripheral Arterial Disease
Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I
04/23/2025
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human...
04/23/2025
Cath Lab Digest
Large-Bore Vascular Closure
Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
04/22/2025
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular...
04/22/2025
Cath Lab Digest
Lower-extremity intervention
First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using R3 Vascular's Magnitude Drug-Eluting Bioresorbable Scaffold
04/22/2025
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its...
04/22/2025
Cath Lab Digest
Uncontrolled Hypertension
Orchestra BioMed Receives FDA Breakthrough Device Designation for Atrioventricular Interval Modulation (AVIM) Therapy.
04/22/2025
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for...
04/22/2025
Cath Lab Digest
Cardiomyopathy
FDA Updates Camzyos (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
04/21/2025
Camzyos is an FDA-approved cardiac myosin inhibitor for the treatment of adults with symptomatic New York Heart Association (NYHA) Class II-III obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms.(1)
Camzyos is an FDA-approved cardiac myosin inhibitor for the treatment of adults with symptomatic New York Heart Association (NYHA) Class II-III obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms.(1)
Camzyos is an FDA-approved...
04/21/2025
Cath Lab Digest

Radiation Protection Systems
Rampart IC Secures Series B Financing to Fuel Strategic Growth and Expand Access to Radiation Safety Solutions
04/24/2025
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology...
04/24/2025
Cath Lab Digest
MEeting Update
SCAI Scientific Sessions 2025 Features Latest Clinical Innovations in Cardiology Care
04/24/2025
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.  
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.  
Whether you’re focused on...
04/24/2025
Cath Lab Digest
Scientific Statement
HRS and ACC Release Joint Scientific Statement on the Safety of Same-Day Discharge for Intracardiac Catheter Ablation Procedures
04/24/2025
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global...
04/24/2025
EP Lab Digest
Heart Disease Research
Link Between Heart Attack Severity and Circadian Rhythm Unveiled by UTHealth Houston Researchers
04/24/2025
“If you have a heart attack in the morning, you are more likely to have fatal arrhythmias, heart failure, and you’re more likely to die from it. The question we asked is ‘Why?’” said Holger Eltzschig, MD, PhD.
“If you have a heart attack in the morning, you are more likely to have fatal arrhythmias, heart failure, and you’re more likely to die from it. The question we asked is ‘Why?’” said Holger Eltzschig, MD, PhD.
“If you have a heart attack in...
04/24/2025
Cath Lab Digest
(Reproduced with permission from NEJM AI, Lampert, 2025. Copyright 2025 Massachusetts Medical Society)
AI: HCM
AI Algorithm Can Help Identify High-Risk Heart Patients to Quickly Diagnose, Expedite, and Improve Care
04/24/2025
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze...
04/24/2025
Cath Lab Digest
News
The Heart Rhythm Society Announces Framework for Establishing Atrial Fibrillation Centers of Excellence and Key Operational Standards
04/23/2025
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS)...
04/23/2025
EP Lab Digest
Peripheral Arterial Disease
Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I
04/23/2025
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human...
04/23/2025
Cath Lab Digest
Large-Bore Vascular Closure
Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
04/22/2025
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular...
04/22/2025
Cath Lab Digest
Lower-extremity intervention
First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using R3 Vascular's Magnitude Drug-Eluting Bioresorbable Scaffold
04/22/2025
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its...
04/22/2025
Cath Lab Digest
Uncontrolled Hypertension
Orchestra BioMed Receives FDA Breakthrough Device Designation for Atrioventricular Interval Modulation (AVIM) Therapy.
04/22/2025
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for...
04/22/2025
Cath Lab Digest

April 2007 Volume 19 Issue 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use